HK$1.53
1.32%
Hong Kong, Sep 22, 04:00 pm HKT. Closed.
ISIN
KYG9390W1015
Symbol
1873

Viva Biotech Holdings Stock price

HK$1.51
-0.08 5.03% 1M
-0.34 18.38% 6M
-0.29 16.11% YTD
-1.07 41.47% 1Y
+0.30 24.79% 3Y
-4.80 76.07% 5Y
-2.91 65.84% 10Y
-2.91 65.84% 20Y
Hong Kong, Closing price Mon, Sep 21 2026
+0.05 3.07%

Is Viva Biotech Holdings a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,133 stocks worldwide.

Key metrics

Basic
Market capitalization
HK$3.0b
Enterprise Value
HK$2.9b
Net debt
positive
Cash
HK$1.2b
Shares outstanding
2.1b
Valuation (TTM | estimate)
P/E
16.8
P/S
1.4 | -
EV/Sales
1.3 | -
EV/FCF
8.2
P/B
0.7
Dividends
DPS
HK$0.00
Yield 1Y | 5Y
0.0% | 0.1%
Growth 1Y | 5Y
- | -100.0%
Payout 1Y | 3Y
0.0% | 0.0%
Increased
0 Years
Financials (TTM | estimate)
Revenue
HK$2.2b | -
EBITDA
HK$425.4m
EBIT
HK$186.7m
Net Income
HK$208.6m
Free Cash Flow
HK$352.8m
Growth (TTM | estimate)
Revenue
3.7% | -
EBITDA
-16.0%
EBIT
-25.8%
Net Income
3.3%
Free Cash Flow
41.1%
Margin
Gross
34.6%
EBITDA
19.1%
EBIT
8.4%
Net
9.4%
Free Cash Flow
15.8%
Financial Health
Equity Ratio
55.5%
Return on Equity
5.5%
ROCE
2.8%
ROIC
2.6%
Debt/Equity
0.2
More
EPS
HK$0.1
FCF per Share
HK$0.2
Short interest
-
Employees
2k
Rev per Employee
HK$930.0k

Viva Biotech Holdings Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Viva Biotech Holdings forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Viva Biotech Holdings forecast:

Buy
86%
Hold
14%

Financial data from Viva Biotech Holdings

Jun '26
+/-
%
2,231 2,231
4% 4%
100%
- Direct Costs 1,460 1,460
8% 8%
65%
771 771
4% 4%
35%
- Selling and Administrative Expenses 411 411
6% 6%
18%
- Research and Development Expense 137 137
37% 37%
6%
425 425
16% 16%
19%
- Depreciation and Amortization 239 239
6% 6%
11%
EBIT (Operating Income) EBIT 187 187
26% 26%
8%
Net Profit 209 209
3% 3%
9%

In millions HKD.

Don't miss a Thing! We will send you all news about Viva Biotech Holdings directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Viva Biotech Holdings engages in the discovery, development, and manufacturing of clinical drugs. The firm has two segments. The Drug Discovery Services segment provides structure-based drug discovery services to biotech and pharmaceutical clients for preclinical innovative drug development. The Contract Design and Manufacturing (CDMO) and Commercialization Services segment is engaged in contract development and manufacturing services for small molecule Active Pharmaceutical Ingredients (APIs) and intermediates, as well as the trading of APIs, intermediates and finished products. The firm conducts business primarily in the United States, China, Europe and other regions.

Head office Cayman Islands
CEO Mr. Mao
Employees 2,169
Website www.vivabiotech.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today